130 related articles for article (PubMed ID: 7824322)
1. [Production of elastase, exotoxin A and alkaline protease during bronchopulmonary exacerbations in patients with mucoviscidosis chronically infected by Pseudomonas aeruginosa].
Jaffar-Bandjee MC; Carrere J; Bally M; Chazalette JP; Galabert C
Pathol Biol (Paris); 1994 May; 42(5):505-9. PubMed ID: 7824322
[TBL] [Abstract][Full Text] [Related]
2. Production of elastase, exotoxin A, and alkaline protease in sputa during pulmonary exacerbation of cystic fibrosis in patients chronically infected by Pseudomonas aeruginosa.
Jaffar-Bandjee MC; Lazdunski A; Bally M; Carrère J; Chazalette JP; Galabert C
J Clin Microbiol; 1995 Apr; 33(4):924-9. PubMed ID: 7790462
[TBL] [Abstract][Full Text] [Related]
3. The combination of PCR and serology increases the diagnosis of Pseudomonas aeruginosa colonization/infection in cystic fibrosis.
da Silva Filho LV; Tateno AF; Martins KM; Azzuz Chernishev AC; Garcia Dde O; Haug M; Meisner C; Rodrigues JC; Döring G
Pediatr Pulmonol; 2007 Oct; 42(10):938-44. PubMed ID: 17722007
[TBL] [Abstract][Full Text] [Related]
4. Pseudomonas aeruginosa and cystic fibrosis: correlation between exoenzyme production and patient's clinical state.
Lanotte P; Mereghetti L; Lejeune B; Massicot P; Quentin R
Pediatr Pulmonol; 2003 Nov; 36(5):405-12. PubMed ID: 14520723
[TBL] [Abstract][Full Text] [Related]
5. Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis.
Hollsing AE; Granström M; Vasil ML; Wretlind B; Strandvik B
J Clin Microbiol; 1987 Oct; 25(10):1868-74. PubMed ID: 3117842
[TBL] [Abstract][Full Text] [Related]
6. Microbiologic contamination study of nebulizers after aerosol therapy in patients with cystic fibrosis.
Vassal S; Taamma R; Marty N; Sardet A; d'athis P; Brémont F; Dalphin ML; Plésiat P; Rault G; Thubert J; Dominique S; Lemeland JF; Derelle J; Blech MF; Roussey M; Perrin M; Sautegeau A
Am J Infect Control; 2000 Oct; 28(5):347-51. PubMed ID: 11029133
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of serum antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis patients.
Ratjen F; Walter H; Haug M; Meisner C; Grasemann H; Döring G
Pediatr Pulmonol; 2007 Mar; 42(3):249-55. PubMed ID: 17243185
[TBL] [Abstract][Full Text] [Related]
8. Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections.
Mowat E; Paterson S; Fothergill JL; Wright EA; Ledson MJ; Walshaw MJ; Brockhurst MA; Winstanley C
Am J Respir Crit Care Med; 2011 Jun; 183(12):1674-9. PubMed ID: 21297072
[TBL] [Abstract][Full Text] [Related]
9. Immunoenzymometric assays for alkaline protease and exotoxin A from Pseudomonas aeruginosa: development and use in detecting exoproteins in clinical isolates from patients with cystic fibrosis.
Jaffar-Bandjee MC; Carrère J; Bally M; Guy-Crotte O; Galabert C
Eur J Clin Chem Clin Biochem; 1994 Dec; 32(12):893-9. PubMed ID: 7696436
[TBL] [Abstract][Full Text] [Related]
10. Infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
Tümmler B; Bosshammer J; Breitenstein S; Brockhausen I; Gudowius P; Herrmann C; Herrmann S; Heuer T; Kubesch P; Mekus F; Römling U; Schmidt KD; Spangenberg C; Walter S
Behring Inst Mitt; 1997 Feb; (98):249-55. PubMed ID: 9382747
[TBL] [Abstract][Full Text] [Related]
11. Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis.
Reid DW; Carroll V; O'May C; Champion A; Kirov SM
Eur Respir J; 2007 Aug; 30(2):286-92. PubMed ID: 17504792
[TBL] [Abstract][Full Text] [Related]
12. Clinical response to azithromycin in cystic fibrosis correlates with in vitro effects on Pseudomonas aeruginosa phenotypes.
Nguyen D; Emond MJ; Mayer-Hamblett N; Saiman L; Marshall BC; Burns JL
Pediatr Pulmonol; 2007 Jun; 42(6):533-41. PubMed ID: 17469154
[TBL] [Abstract][Full Text] [Related]
13. [Effects of azithromycin on the virulence of Pseudomonas aeruginosa].
Reinert P
Pathol Biol (Paris); 1995 Jun; 43(6):551-3. PubMed ID: 8539081
[TBL] [Abstract][Full Text] [Related]
14. Pseudomonas aeruginosa and Burkholderia cepacia cannot be detected by PCR in the breath condensate of patients with cystic fibrosis.
Vogelberg C; Hirsch T; Rösen-Wolff A; Kerkmann ML; Leupold W
Pediatr Pulmonol; 2003 Oct; 36(4):348-52. PubMed ID: 12950050
[TBL] [Abstract][Full Text] [Related]
15. Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population.
Bradbury R; Champion A; Reid DW
Respirology; 2008 Nov; 13(6):886-92. PubMed ID: 18811887
[TBL] [Abstract][Full Text] [Related]
16. A novel chromogenic medium for isolation of Pseudomonas aeruginosa from the sputa of cystic fibrosis patients.
Laine L; Perry JD; Lee J; Oliver M; James AL; De La Foata C; Halimi D; Orenga S; Galloway A; Gould FK
J Cyst Fibros; 2009 Mar; 8(2):143-9. PubMed ID: 19097827
[TBL] [Abstract][Full Text] [Related]
17. Microbiological background for anti-Pseudomonas aeruginosa vaccination in cystic fibrosis.
Bauernfeind A; Przyklenk B
Behring Inst Mitt; 1997 Feb; (98):256-61. PubMed ID: 9382748
[No Abstract] [Full Text] [Related]
18. [Anti-Pseudomonas aeruginosa antibodies, circulating immune complexes, and anticytoplasm antibodies of neutrophils in patients with cystic fibrosis with and without Pseudomonas aeruginosa colonization].
Chiappini E; Taccetti G; Campana S; Turchini S; Marianelli L
Pediatr Med Chir; 2001; 23(1):27-30. PubMed ID: 11486418
[TBL] [Abstract][Full Text] [Related]
19. Corneal virulence of Pseudomonas aeruginosa elastase B and alkaline protease produced by Pseudomonas putida.
Thibodeaux BA; Caballero AR; Marquart ME; Tommassen J; O'Callaghan RJ
Curr Eye Res; 2007 Apr; 32(4):373-86. PubMed ID: 17453960
[TBL] [Abstract][Full Text] [Related]
20. Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study.
Hansen CR; Pressler T; Koch C; Høiby N
J Cyst Fibros; 2005 Mar; 4(1):35-40. PubMed ID: 15752679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
